Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Nov 14, 2012	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-12-000030.pdf 0000320017-12-000030.rtf 0000320017-12-000030.xls
Nov 13, 2012	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000320017-12-000019.pdf 0000320017-12-000019.rtf 0000320017-12-000019.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Nov 13, 2012	S-8 POS	Post-effective amendment to an S-8 filing	View HTML 0000320017-12-000021.pdf 0000320017-12-000021.rtf
Nov 13, 2012	S-8 POS	Post-effective amendment to an S-8 filing	View HTML 0000320017-12-000023.pdf 0000320017-12-000023.rtf
Nov 13, 2012	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0000320017-12-000025.pdf 0000320017-12-000025.rtf 0000320017-12-000025.xls
Nov 13, 2012	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-12-061143.pdf 0001144204-12-061143.rtf 0001144204-12-061143.xls
Oct 26, 2012	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-12-058124.pdf 0001144204-12-058124.rtf 0001144204-12-058124.xls
Oct 25, 2012	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-12-000016.pdf 0000320017-12-000016.rtf 0000320017-12-000016.xls
Oct 5, 2012	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-12-000014.pdf 0000320017-12-000014.rtf 0000320017-12-000014.xls
Oct 3, 2012	EFFECT	EFFECT	View HTML 9999999995-12-002881.pdf 9999999995-12-002881.rtf 9999999995-12-002881.xls